Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001708138-20-000106

Director sold 6,090 shares at $552.36 ($3,363,872)

  • Director acquired 5,090 shares (option exercise)
  • Director gave 1,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

BROWN MICHAEL S · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-22 Exercise or conversion : show line 1 in the form +2,480 $380.95 $944,756 3,123 D
2020-09-22 Exercise or conversion : show line 2 in the form +2,610 $376.69 $983,161 5,733 D
2020-09-22 Sale : show line 3 in the form −5,090 $552.36 $2,811,512 643 D
2020-05-13 Gift : show line 4 in the form −1,000 10,349 I
2020-09-22 Sale : show line 5 in the form −1,000 $552.36 $552,360 9,349 I
Open-market sales · 6,090 sh · avg $552.36 · $3,363,872

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-09-22 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −2,610 $376.69 2027-01-03 2,610 0 D
2020-09-22 Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) −2,480 $380.95 2028-01-02 2,480 4,959 D
Loading xslF345X03/edgardoc.xml…